[New contributions on extinction tests of essential headache. II. The test with indoprofen].
The authors described the results about the action of indoprofen (i.v. 400 mg) in three subjects affected by premenstrual migraine. They showed decreased levels of PGF2 alpha in the cerebrospinal fluid evaluated by gas-chromatography and mass spectrometry. The samples were extracted at 0, 15, 30 and 45 minutes. The levels of pain, was also decreased, they were evaluated by the analogic visual scale (V.A.S.).
D000328:Adult; D015237:Dinoprost; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry; D006261:Headache / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007216:Indoprofen / Q000627:therapeutic use*; D010666:Phenylpropionates / Q000627:therapeutic use*; D011293:Premenstrual Syndrome / Q000150:complications / Q000188:drug therapy; D011460:Prostaglandins F / Q000134:cerebrospinal fluid
D010666:Phenylpropionates; D011460:Prostaglandins F; D015237:Dinoprost; D007216:Indoprofen
Nuovi contributi su le prove di estinzione nelle cefalee essenziali: II) Il test con indoprofene.